Enovis Corporation

ENOV ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-1.18B $-825.5M $-33.3M $-13.3M $71.7M $42.6M $-527.6M $140.2M
Depreciation & Amortization $1.34B $927.8M $217.1M $203.0M $187.0M $167.9M $215.6M $81.2M
Depreciation — — — — — — — —
Amortization $173.6M $165.5M $133.5M $126.3M $116.9M $103.3M $135.8M $43.7M
Stock-Based Compensation $32.9M $29.7M $34.1M $39.0M $35.4M $28.9M $22.0M $25.1M
Net Cash from Operating Activities $217.3M $113.5M $135.0M $-55.9M $356.1M $301.9M $130.9M $226.4M
Investing Activities
Capital Expenditures $197.4M $180.7M $122.2M $105.5M $104.2M $114.8M $125.4M $69.6M
Business Acquisitions $26.9M $769.9M $152.8M $73.7M $223.3M $69.8M $3.15B $290.9M
Net Cash from Investing Activities $-179.4M $-955.5M $-242.5M $-176.4M $-320.5M $-175.1M $-1.63B $-167.9M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $3.5M $4.8M $0 $0 — $0 $0 $200.0M
Net Cash from Financing Activities $-52.4M $846.8M $127.8M $-465.1M $584.9M $-131.7M $1.37B $-47.2M
Net Change in Cash $-11.8M $3.3M $20.5M $-695.1M $618.3M $-8.6M $-135.4M $-17.0M
Free Cash Flow $19.9M $-67.2M $12.8M $-161.3M $251.9M $187.2M $5.5M $156.7M
← Newer Page 1 of 3 Older →